TG THERAPEUTICS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
TG THERAPEUTICS, INC. (TGTX) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2014-05-14
- TG THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2014-03-31 was $0.00.
- TG THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2013-12-31 was $0.00.
- TG THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2013-09-30 was $0.00.
- TG THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2013-06-30 was $0.00.
- TG THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2013 was $0.00.
- TG THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2012 was -$8.11M.
- TG THERAPEUTICS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2011 was -$36.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 13 month | Net Income (Loss) Attributable to Noncontrolling Interest 15 month | Net Income (Loss) Attributable to Noncontrolling Interest 16 month | Net Income (Loss) Attributable to Noncontrolling Interest 18 month | Net Income (Loss) Attributable to Noncontrolling Interest 19 month | Net Income (Loss) Attributable to Noncontrolling Interest 22 month | Net Income (Loss) Attributable to Noncontrolling Interest 25 month | Net Income (Loss) Attributable to Noncontrolling Interest 28 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | -$8.15M 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $0.00 derived: sum of 3 quarters · filed 2014-03-07 | $0.00 10-K · filed 2014-03-07 | -$8.15M 10-K · filed 2014-03-07 | |||||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | -$42.32K derived: sum of 4 quarters · filed 2014-05-14 | -$8.15M 10-Q · filed 2013-11-14 | |||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | -$42.32K derived: sum of 3 quarters · filed 2014-05-14 | -$290.28K derived: sum of 4 quarters · filed 2014-05-14 | -$8.15M 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | -$42.32K derived: sum of 2 quarters · filed 2014-05-14 | -$290.28K derived: sum of 3 quarters · filed 2014-05-14 | -$969.78K derived: sum of 4 quarters · filed 2014-05-14 | -$8.15M 10-Q · filed 2013-05-14 | |||||||
| 2012-12-31 | -$42.32K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$290.28K derived: sum of 2 quarters · filed 2014-03-07 | -$969.78K derived: sum of 3 quarters · filed 2014-03-07 | -$8.11M 10-K · filed 2014-03-07 | -$8.15M 10-K · filed 2013-03-21 | |||||||
| 2012-09-30 | -$247.96K 10-Q · filed 2013-11-14 | -$927.47K derived: sum of 2 quarters · filed 2013-11-14 | -$8.07M 10-Q · filed 2013-11-14 | -$8.09M derived: sum of 4 quarters · filed 2013-11-14 | -$8.10M 10-Q · filed 2012-11-14 | |||||||
| 2012-06-30 | -$679.51K 10-Q · filed 2013-08-09 | -$7.82M 10-Q · filed 2013-08-09 | -$7.84M derived: sum of 3 quarters · filed 2013-08-09 | -$7.84M derived: sum of 4 quarters · filed 2013-08-09 | -$7.86M 10-Q/A · filed 2012-09-07 | |||||||
| 2012-03-31 | -$7.14M 10-Q · filed 2013-05-14 | -$7.16M derived: sum of 2 quarters · filed 2013-05-14 | -$7.16M derived: sum of 3 quarters · filed 2013-05-14 | -$7.18M 10-Q · filed 2012-05-14 | ||||||||
| 2011-12-31 | -$19.59K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | -$21.10K derived: sum of 2 quarters · filed 2013-03-21 | -$36.00K derived: sum of 3 quarters · filed 2013-03-21 | -$36.00K 10-K · filed 2013-03-21 | ||||||||
| 2011-09-30 | -$1.51K 10-Q · filed 2012-11-14 | -$16.41K derived: sum of 2 quarters · filed 2012-11-14 | -$16.41K 10-Q · filed 2012-11-14 | |||||||||
| 2011-06-30 | -$14.89K 10-Q/A · filed 2012-09-07 | -$14.89K 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |